PolyPid Ltd. Announces Shareholder Meeting for July 2
Ticker: PYPD · Form: 6-K · Filed: May 28, 2024 · CIK: 1611842
| Field | Detail |
|---|---|
| Company | Polypid Ltd. (PYPD) |
| Form Type | 6-K |
| Filed Date | May 28, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, proxy-statement, corporate-governance
TL;DR
PolyPid shareholders: Meeting July 2, vote by June 3. Proxy materials out.
AI Summary
PolyPid Ltd. has filed a Form 6-K on May 28, 2024, to announce its Annual and Extraordinary General Meeting of Shareholders. The meeting is scheduled for Tuesday, July 2, 2024, and shareholders of record as of June 3, 2024, will be eligible to vote. The filing includes the Notice of Meeting, Proxy Statement, and Proxy Card.
Why It Matters
This filing informs shareholders about an upcoming meeting where important corporate decisions will be made, allowing them to exercise their voting rights.
Risk Assessment
Risk Level: low — This is a routine corporate filing announcing a shareholder meeting, not indicating any immediate financial or operational risks.
Key Players & Entities
- PolyPid Ltd. (company) — Registrant
- July 2, 2024 (date) — Annual and Extraordinary General Meeting date
- June 3, 2024 (date) — Record date for shareholder eligibility to vote
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K filing is to report PolyPid Ltd.'s Notice of Meeting, Proxy Statement, and Proxy Card for its Annual and Extraordinary General Meeting of Shareholders.
When is the Annual and Extraordinary General Meeting of Shareholders scheduled to take place?
The Annual and Extraordinary General Meeting of Shareholders is scheduled to be held on Tuesday, July 2, 2024.
Who is eligible to receive notice of and vote at the meeting?
Shareholders of record who hold ordinary shares of PolyPid Ltd. at the close of business on June 3, 2024, will be entitled to notice of and to vote at the meeting.
What documents are included with this filing?
This filing includes the Notice of Meeting, Proxy Statement, and Proxy Card for the Annual and Extraordinary General Meeting of Shareholders.
What is the company's principal executive office address?
The company's principal executive office is located at 18 Hasivim Street, Petach Tikva 495376, Israel.
Filing Stats: 352 words · 1 min read · ~1 pages · Grade level 9.9 · Accepted 2024-05-28 16:05:16
Filing Documents
- ea0206932-6k_polypid.htm (6-K) — 14KB
- ea020693201ex99-1_polypid.htm (EX-99.1) — 14KB
- ea020693201ex99-2_polypid.htm (EX-99.2) — 91KB
- ea020693201ex99-3_polypid.htm (EX-99.3) — 43KB
- 0001213900-24-047069.txt ( ) — 162KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. POLYPID LTD. Date: May 28, 2024 By: /s/ Dikla Czaczkes Akselbrad Name: Dikla Czaczkes Akselbrad Title: Chief Executive Officer 3